Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.46 |
| ▸ | NPY1R | P25929 | 7/20 | 0.46 |
| ▸ | NPY2R | P49146 | 5/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.46 |
| ▸ | APLNR | P35414 | 1/20 | 0.45 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.43 |
| ▸ | GLP1R | P43220 | 1/20 | 0.41 |
| ▸ | SCTR | P47872 | 1/20 | 0.41 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.41 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.40 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710592 | 0.95 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RAPLNR | |
| SCHEMBL6710584 | 0.95 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RAPLNR | |
| SCHEMBL30851295 | 0.93 | NPY4R (0.52) | NPY4RNPY1RNPY2RNPY5RAPLNR | |
| SCHEMBL31139071 | 0.92 | APLNR (0.48) | NPY4RNPY1RNPY2RNPY5RAPLNR | |
| SCHEMBL29659741 | 0.90 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RC5AR1 | |
| SCHEMBL30823264 | 0.90 | APLNR (0.50) | NPY4RNPY1RNPY2RNPY5RAPLNR | |
| SCHEMBL29939588 | 0.90 | C5AR1 (0.49) | APLNRC5AR1GLP1RSCTRIL23R | |
| SCHEMBL29948315 | 0.89 | C5AR1 (0.46) | NPY4RNPY1RNPY2RNPY5RC5AR1 | |
| SCHEMBL30645267 | 0.88 | NPY4R (0.53) | NPY4RNPY1RNPY2RNPY5RAPLNR | |
| SCHEMBL30490412 | 0.88 | NPY4R (0.52) | NPY4RNPY1RNPY2RNPY5RAPLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509489-B2 | Oligopeptide | ZEON CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20240199694-A1 | OLIGOPEPTIDE | ZEON CORPORATION (JP) | 2024-06-20 | — | — | US | disclosed |
| US-11926679-B2 | Oligopeptide search method, oligopeptide, modified peptide, and immunoassay method | ZEON CORPORATION (JP) | 2024-03-12 | — | — | US | disclosed |
| CN-117209564-A | Oligopeptide searching method, oligopeptide and modified peptide | 日本瑞翁株式会社 | 2023-12-12 | — | — | CN | disclosed |
| CN-110191894-B | Method for searching oligopeptide, modified peptide and immunoassay method | 日本瑞翁株式会社 | 2023-09-05 | — | — | CN | disclosed |
| US-20230047436-A1 | OLIGOPEPTIDE SEARCH METHOD, OLIGOPEPTIDE, MODIFIED PEPTIDE, AND IMMUNOASSAY METHOD | ZEON CORPORATION (JP) | 2023-02-16 | — | — | US | disclosed |
| US-11485757-B2 | Oligopeptide search method, oligopeptide, modified peptide, and immunoassay method | ZEON CORPORATION (JP) | 2022-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509489-B2 | Oligopeptide | FN1, HGF, TNFSF11 | NPY4R 1138/4885NPY1R 519/4885NPY2R 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.